Enzo Life Sciences的MITO-ID® Membrane potential cytotoxicity kit利用陽離子雙發(fā)射染料檢測線粒體膜電位（MMP）的波動，該染料在細胞質(zhì)中以綠色熒光單體的形式存在，在線粒體中以橙色熒光J聚集體的形式聚集。具有低膜電位的線粒體將積累低濃度的染料并呈現(xiàn)綠色熒光，而更高度極化的線粒體將呈現(xiàn)橙紅色熒光。隨著線粒體功能受損加劇，細胞表現(xiàn)出從橙色熒光到綠色熒光的轉(zhuǎn)變。該試劑盒是一種獨-特的HTS測定法，無需洗滌或去除培養(yǎng)基即可實時監(jiān)測線粒體膜電位。

產(chǎn)品特點

● 靈敏度是JC-1熒光染料的10倍，并具有卓-越的水溶性

● 具備光穩(wěn)定性的雙發(fā)射染料

● 無需漂洗/換液步驟

● 單獨的MITO-ID®檢測可用于檢測線粒體質(zhì)量

● 可在較低的藥物/劑量濃度下檢測細胞毒性

● 沒有使用JC-1染料時出現(xiàn)的溶劑偽影

● 適用于高通量應用

實驗示例

圖1. 檢測線粒體紊亂的靈敏度是JC-1的10倍。使用MITO-ID®膜電位染料（紅色）或JC-1（藍色）在經(jīng)CCCP處理的HeLa細胞中評估線粒體膜電位（MMP）。使用傳統(tǒng)的熒光酶標儀檢測，結(jié)果顯示MMP 隨著CCCP濃度的增加而減少，橙色熒光減少。染料的水溶性優(yōu)化和無需洗滌的實驗方案最大限度減小了可變性，因此Z因子（>0.9）高于使用JC-1.

圖2. 在藥物篩選中實時檢測有絲分裂毒性。使用BioTek Synergy™ Mx熒光酶標儀對線粒體膜電位變化的時間進程研究。HeLa細胞與MITO-ID®膜電位染料在室溫下孵育30分鐘（不去除血清或培養(yǎng)基）。添加魚藤酮分別達到1µM、3µM和9µM的濃度。橙色信號的減少證明染料對魚藤酮有反應。

產(chǎn)品信息

部分產(chǎn)品引用文獻

1. Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Management: M. Pellei, et al.; Int. J. Mol. Sci. 24, 4091 (2023) 

2. FUNDC1 regulates receptor-mediated mitophagy independently of the PINK1/Parkin-dependent pathway in rotenone-treated SH-SY5Y cells: S.Y. Park, et al.; Food Chem. Toxicol. 137, 111163 (2020), Application(s): Fluorescence microscopy and microplate reader

3. Inhibitory role of TRIP-Br1/XIAP in necroptosis under nutrient/serum starvation: Z. Sandag, et al.; Mol. Cells 43, 236 (2020) 

4. NAD hydrolysis by the tuberculosis necrotizing toxin induces lethal oxidative stress in macrophages: D. Pajuelo, et al.; Cell. Microbiol. 22, e13115 (2020), Application(s): THP-1 macrophages; microplate reader

5. Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases: M.M. Ivanova, et al.; PLoS One 14, e0210617 (2019), Application(s): Fluorescence microscopy 

6. Inhibitory role of AMPactivated protein kinase in necroptosis of HCT116 colon cancer cells with p53 null mutation under nutrient starvation: D.T. Le, et al.; Int. J. Oncol. 54, 702 (2019) 

7. ROS as a novel indicator to predict anticancer drug efficacy: T. Zaidieh, et al.; BMC Cancer 19, 1224 (2019) 

8. TREM1/3 deficiency impairs tissue repair after acute kidney injury and mitochondrial metabolic flexibility in tubular epithelial cells: A. Tammaro, et al.; Front. Immunol. 10, 1469 (2019), Application(s): Microplate reader

9. Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths: S. Jung, et al.; Oncotarget 9, 16744 (2018), Application(s): Microplate reader 

10. Blue light phototoxicity toward human corneal and conjunctival epithelial cells in basal and hyperosmolar conditions: V. Marek, et al.; Free Radic. Biol. Med. 126, 27 (2018), Application(s): Microplate reader

11. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration: N. Kerur, et al.; Nat. Med. 24, 50 (2018)

12. Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes: K. Kido, et al.; J. Anesth. 32, 120 (2018), Application(s): Microplate reader

13. Development of novel amino-quinoline-5, 8-dione derivatives as NAD (P) H: quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities: Y. Ling, et al.; Eur. J. Med. Chem. 154, 199 (2018)

14. Inhibition of apoptosis using exosomes in Chinese hamster ovary cell culture: S. Han, et al.; Biotechnol. Bioeng. 115, 1331 (2018)

15. Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells: M. Marie, et al.; Cell Death Disc. 9, 287 (2018)

詳情請聯(lián)系Enzo Life Sciences金牌代理——欣博盛生物